跳至主要内容
临床试验/ISRCTN89683704
ISRCTN89683704已完成不适用

A single centre randomised interventional trial of additional education and advice about glaucoma verus standard care in improving adherence with topical anti-glaucomatous therapy

orfolk and Norwich University Hospitals NHS Foundation Trust (UK)0 个研究点目标入组 200 人开始时间: 2010年5月12日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • Added 22/12/2010:
  • 1. Newly diagnosed or previously untreated glaucoma patients and ocular hypertension patients prescribed Travoprost
  • 2. Over 18 years old, no upper age limit
  • 3. Male and female

排除标准

  • Does not meet inclusion criteria

研究者

发起方
orfolk and Norwich University Hospitals NHS Foundation Trust (UK)

相似试验

尚未招募
1 期
A single center, randomized controlled trial on the treatment of elderly patients with acute myeloid leukemia by attack and reinforcement combined with demethylatio
ITMCTR2000003828Yueyang integrated traditional Chinese and Western Medicine Hospital Affiliated to Shanghai University of traditional Chinese Medicine
进行中(未招募)
不适用
Can supplementation with Omega-3 fatty acids in preterm infants improve visual and cognitive outcome?Premature male/female infants, <28 gestational weeks at birth with risk of developing retinopathy of prematurity (ROP)
EUCTR2008-000046-31-SEThe Sahlgrenska Center for Pediatric Ophtalmology Research
已完成
不适用
Video image vs virtual reality in theatre to distract children: the VIVID trialChildren undergoing elective or emergency surgeryAnaesthesiology - Other anaesthesiologySurgery - Other surgery
ACTRN12622000085774Child & Adolescent Health Service Executive at Perth Children's Hopsital200
进行中(未招募)
1 期
Influence of tranexamic acid on blood loss for total joint replacementOsteoarthritic patients who require hip or knee arthroplasty
EUCTR2015-002661-36-GBBelfast Health and Social Care Trust1,166
已完成
不适用
A single centre randomised clinical trial to assess the antibody response to a 23-valent pneumococcal polysaccharide vaccine administered to adults aged between 50 - 70 years following a 0, 1 or 2 dose priming immunisation with a 7-valent pneumococcal conjugate vaccine
ISRCTN78768849niversity of Oxford (UK)348